hotspot -WSS

hotspot

author：comprehensive 2025-09-29 01:35:59 - browse：7587

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Can we make enough H5N1 bird flu vaccine if there's a pandemic?

leisure time

WSS

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Amylyx ALS drug fails large clinical trial

Venture capitalist Bob Kocher on the state of digital health

Big Tobacco's 'harm reduction': Is it for real, or a sham?

NEJM study link tiny plastics in blood vessels to heart problems

Wikipedia

hotspot

explore

Supreme Court strikes down use of affirmative action

Addiction experts warn against a second 'war on drugs'

Hollywood unions extend contract negotiations for actors

Criminal prosecution for violating HIPAA: an emerging threat

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Continuity nursing helped my family in our darkest PICU moments

Second House panel advances two

explore

It's time to retire 'poor historian' from clinicians' vocabularies

Wearables generate powerful data but its not useful to doctors, yet

What it’s like to watch children die of measles

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Data integrity in scientific journals requires "effort" by publishers, institutions

leisure time

leisure time

Wikipedia

leisure time